$IMG
NuZee, Inc. Stock $img

$img Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017297 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$648.6K	$781.2K	$715.1K
YoY Change	-16.2%	9.24%	74.41%
Cost Of Revenue	$596.5K	$744.5K	$714.1K
YoY Change	-30.46%	4.26%	70.02%
Gross Profit	$52.15K	$36.63K	$980.00
YoY Change	-162.34%	3637.76%	-109.8%
Gross Profit Margin	8.04%	4.69%	0.14%
Selling, General & Admin	$18.04K	$38.17K
YoY Change
% of Gross Profit	34.59%	104.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$68.69K	$38.83K	$129.5K
YoY Change	-46.76%	-70.0%	223.62%
% of Gross Profit	131.71%	106.01%	13209.18%
Operating Expenses	$2.068M	$1.983M	$3.196M
YoY Change	-18.8%	-37.97%	-47.68%
Operating Profit	-$2.016M	-$1.946M	-$3.195M
YoY Change	-23.36%	-39.09%	-47.79%
Interest Expense	$1.550K	$5.350K	-$3.560K
YoY Change	-23.38%	-250.28%	-64.4%
% of Operating Profit
Other Income/Expense, Net	-$11.13K	-$26.92K	-$24.65K
YoY Change	-3690.32%	9.21%	-161.63%
Pretax Income	-$2.025M	-$1.968M	-$3.224M
YoY Change	-23.1%	-38.96%	-47.07%
Income Tax
% Of Pretax Income
Net Earnings	-$2.025M	-$1.968M	-$3.224M
YoY Change	-23.1%	-38.96%	-47.03%
Net Earnings / Revenue	-312.26%	-251.91%	-450.82%
Basic Earnings Per Share	-$2.63	-$2.80	-$6.17
Diluted Earnings Per Share	-$2.63	-$2.80	-$176.2K
COMMON SHARES
Basic Shares Outstanding	769.2K shares	691.1K shares	522.9K shares
Diluted Shares Outstanding	770.1K shares	702.9K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.280M	$4.699M	$8.212M
YoY Change	-56.4%	-42.77%	-45.4%
Cash & Equivalents	$3.280M	$4.699M	$8.212M
Short-Term Investments
Other Short-Term Assets	$283.3K	$301.4K	$1.012M
YoY Change	-75.88%	-70.23%	678.8%
Inventory	$1.279M	$1.230M	$631.3K
Prepaid Expenses
Receivables	$216.5K	$421.6K	$646.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.060M	$6.652M	$10.50M
YoY Change	-49.17%	-36.66%	-32.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$360.0K	$402.8K	$1.523M
YoY Change	-41.2%	-73.55%	8.79%
Goodwill
YoY Change
Intangibles	$117.5K	$125.0K
YoY Change	-61.29%
Long-Term Investments	$164.3K	$166.1K	$173.1K
YoY Change	-4.05%	-4.04%	-3.82%
Other Assets	$83.73K	$87.22K	$105.4K
YoY Change	-3.48%	-17.21%	31.69%
Total Long-Term Assets	$1.196M	$1.300M	$2.656M
YoY Change	-50.9%	-51.05%	60.02%
TOTAL ASSETS
Total Short-Term Assets	$5.060M	$6.652M	$10.50M
Total Long-Term Assets	$1.196M	$1.300M	$2.656M
Total Assets	$6.256M	$7.952M	$13.16M
YoY Change	-49.51%	-39.57%	-24.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.152M	$210.2K	$839.1K
YoY Change	152.44%	-74.95%	1997.8%
Accrued Expenses	$297.5K	$756.7K	$526.9K
YoY Change	-39.57%	43.61%	-43.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$35.37K	$38.41K	$49.18K
YoY Change	-8.13%	-21.9%	-38.53%
Total Short-Term Liabilities	$1.879M	$1.778M	$2.050M
YoY Change	22.81%	-13.29%	44.38%
LONG-TERM LIABILITIES
Long-Term Debt	$3.800K	$6.870K	$45.61K
YoY Change	-89.57%	-84.94%	-49.32%
Other Long-Term Liabilities	$47.22K	$81.13K	$593.0K
YoY Change	-41.57%	-86.32%	79.71%
Total Long-Term Liabilities	$214.2K	$230.8K	$638.7K
YoY Change	-68.64%	-63.87%	52.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.879M	$1.778M	$2.050M
Total Long-Term Liabilities	$214.2K	$230.8K	$638.7K
Total Liabilities	$2.093M	$2.009M	$2.689M
YoY Change	-5.41%	-25.3%	46.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$70.80M	-$68.77M
YoY Change	15.15%
Common Stock	$74.82M	$74.56M
YoY Change	4.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.163M	$5.944M	$10.47M
YoY Change
Total Liabilities & Shareholders Equity	$6.256M	$7.952M	$13.16M
YoY Change	-49.51%	-39.57%	-24.07%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.025M	-$1.968M	-$3.224M
YoY Change	-23.1%	-38.96%	-47.03%
Depreciation, Depletion And Amortization	$68.69K	$38.83K	$129.5K
YoY Change	-46.76%	-70.0%	223.62%
Cash From Operating Activities	-$1.375M	-$1.737M	-$2.574M
YoY Change	-9.73%	-32.53%	111.01%
INVESTING ACTIVITIES
Capital Expenditures	$18.37K	$0.00	-$162.7K
YoY Change	-137.62%	-100.0%	171.13%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$373.8K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$18.37K	$0.00	-$536.5K
YoY Change	-79.14%	-100.0%	794.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.100K	-12.70K	362.5K
YoY Change	-100.63%	-103.5%	-96.7%
NET CHANGE
Cash From Operating Activities	-1.375M	-1.737M	-2.574M
Cash From Investing Activities	-18.37K	0.000	-536.5K
Cash From Financing Activities	-6.100K	-12.70K	362.5K
Net Change In Cash	-1.399M	-1.750M	-2.748M
YoY Change	117.51%	-36.34%	-128.3%
FREE CASH FLOW
Cash From Operating Activities	-$1.375M	-$1.737M	-$2.574M
Capital Expenditures	$18.37K	$0.00	-$162.7K
Free Cash Flow	-$1.393M	-$1.737M	-$2.412M
YoY Change	-5.5%	-27.98%	107.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001527613
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	NUZE	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	NUZE	Advances Received Of Sale Of Equity Securities AdvancesReceivedOfSaleOfEquitySecurities		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts		usd
	NUZE	Stock Issuance Cost Accrued StockIssuanceCostAccrued		usd
	NUZE	Addition For Right Of Use Of Assets AdditionForRightOfUseOfAssets		usd
	NUZE	Addition For Lease Liability AdditionForLeaseLiability		usd
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q1	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39338
	dei	Entity Registrant Name EntityRegistrantName	NUZEE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3849791
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1350 East Arapaho Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite #230
	dei	Entity Address City Or Town EntityAddressCityOrTown	Richardson
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75081
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	295-2408
	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
	dei	Trading Symbol TradingSymbol	NUZE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	769239	shares
CY2023Q1	us-gaap	Cash Cash	4699227	usd
CY2022Q3	us-gaap	Cash Cash	8315053	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421568	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	345258	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1229903	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	301380	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547773	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	6652078	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	10156079	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	402844	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	519119	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642624	usd
CY2023Q1	us-gaap	Investments Investments	166137	usd
CY2022Q3	us-gaap	Investments Investments	169634	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	125000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	140000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87223	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77962	usd
CY2023Q1	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	897479	usd
CY2022Q3	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	1030220	usd
CY2023Q1	us-gaap	Assets Assets	7952401	usd
CY2022Q3	us-gaap	Assets Assets	11711374	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	210202	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	113708	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	8746	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	7947	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377005	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	388325	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	29665	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24518	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	756701	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	706492	usd
CY2023Q1	us-gaap	Deferred Income Current DeferredIncomeCurrent	322277	usd
CY2022Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	319707	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	73170	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39241	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1777766	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1599938	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	142776	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	267786	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6859	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	29622	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	7	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	4745	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	81130	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66484	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	230772	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	368637	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2008538	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1968575	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	769239	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	769239	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	676229	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	676229	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	8	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	7	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74560942	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74281418	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68773599	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64622520	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	156512	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	83894	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5943863	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7952401	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11711374	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	781166	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	715073	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1917514	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1734326	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	744536	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	714092	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1805352	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1717974	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	36630	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	981	usd
	us-gaap	Gross Profit GrossProfit	112162	usd
	us-gaap	Gross Profit GrossProfit	16352	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1982929	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	3196479	usd
	us-gaap	Operating Expenses OperatingExpenses	4260129	usd
	us-gaap	Operating Expenses OperatingExpenses	6007668	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1946299	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3195498	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4147967	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5991316	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1673	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1139	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3497	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2296	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	62464	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	42461	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	113202	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	85218	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	89387	usd
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	67106	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	125177	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	114528	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7022	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2415	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12360	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4978	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3223697	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4151079	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6027900	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.80
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.62
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	702862	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	522872	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	689550	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	518711	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3223697	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-42965	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7095	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42965	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7095	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2010838	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3230792	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4151079	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6027900	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	72618	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	25593	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	72618	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25593	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4078461	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6002307	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	197108	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	62839	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	115583	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2183206	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7935123	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	57120	shares
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	25000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-114482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	51940	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42965	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5943863	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12212447	usd
CY2021Q4	NUZE	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1721018	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1124187	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	32688	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-2804203	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12286137	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12286137	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18422	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	88426	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	386844	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	935447	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12600	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	9590	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7095	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3223697	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10469830	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10469830	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4151079	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6027900	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	112637	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	166161	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	123505	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	94544	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	82626	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2059634	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	57120	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	114779	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	9590	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	67003	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-41108	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-12618	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3497	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2296	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	143313	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	91648	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281908	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	48156	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-246393	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	432286	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	9261	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	25527	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	96494	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	398464	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2570	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	113209	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-136330	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-91525	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	109138	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-305129	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	14646	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	11627	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3650375	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4154028	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16514	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165689	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	373832	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16514	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-539521	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12600	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3939	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	28047	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	17616	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	11870	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	88426	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1702596	usd
	NUZE	Advances Received Of Sale Of Equity Securities AdvancesReceivedOfSaleOfEquitySecurities	300000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21555	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2063705	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	72618	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25593	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3615826	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2604251	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8315053	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10815954	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4699227	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8211703	usd
	us-gaap	Interest Paid Net InterestPaidNet	2034	usd
	us-gaap	Interest Paid Net InterestPaidNet	5390	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	558371	usd
	us-gaap	Stock Issued1 StockIssued1	386844	usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts	25000	usd
	NUZE	Stock Issuance Cost Accrued StockIssuanceCostAccrued	97867	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	l-for-35 reverse stock split
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	256291	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	249771	shares
CY2023Q1	us-gaap	Cash Cash	4699227	usd
CY2023Q1	NUZE	Working Capital WorkingCapital	4874312	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642624	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	123505	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	519119	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	656111	usd
	NUZE	Operating Lease Lease Liability Amortization Expense OperatingLeaseLeaseLiabilityAmortizationExpense	136330	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	519781	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377005	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	142776	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	519781	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	392186	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	166582	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	558768	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	38987	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	519781	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377005	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	142776	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2023Q1	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1275	pure
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2033	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	33113	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	11037	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	44150	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	7626	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	36524	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	29665	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6859	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	160271	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2033	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17616	usd
	us-gaap	Sublease Income SubleaseIncome	90263	usd
CY2023Q1	NUZE	Sub Lease Liability Payments Due Next Twelve Months SubLeaseLiabilityPaymentsDueNextTwelveMonths	128881	usd
CY2023Q1	NUZE	Sublease Liability Payments Due Year Two SubleaseLiabilityPaymentsDueYearTwo	32459	usd
CY2023Q1	NUZE	Minimum Lease Payments To Be Received Sublease MinimumLeasePaymentsToBeReceivedSublease	161340	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	72618	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	25593	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	301380	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	547773	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	301380	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	547773	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1229903	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1134311	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	887632	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	95592	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	60363	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1229903	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3497	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2296	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1917514	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1734326	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	402844	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	531412	usd
CY2022Q3	us-gaap	Goodwill Goodwill	0	usd
CY2022	NUZE	Non Cash Impairment Charges For The Dripkit Tradename NonCashImpairmentChargesForTheDripkitTradename	80555	usd
CY2022	NUZE	Non Cash Impairment Charges For Acquried Customer NonCashImpairmentChargesForAcquriedCustomer	63167	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1207	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9757	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	120.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	103893	shares
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	772165	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1811693	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3025896	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	5866279	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15000	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2458	shares
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1702596	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9757	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	113650	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	149.88
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	152.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1909	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	69579	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	171.68
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	50009	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	154.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	8883	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	107.79
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	6812	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	283.56
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	34314	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	140.60
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	152398	shares
CY2022Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	158.24
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P3Y8M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	152398	shares
CY2023Q1	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	158.24
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Ending Balance SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermEndingBalance	P3Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther	152398	shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice	158.24
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable	P3Y2M12D
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	150000	usd

Files In Submission

Name	View Source	Status
0001493152-23-017297-index-headers.html	Edgar Link	pending
0001493152-23-017297-index.html	Edgar Link	pending
0001493152-23-017297.txt	Edgar Link	pending
0001493152-23-017297-xbrl.zip	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuze-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nuze-20230331_cal.xml	Edgar Link	unprocessable
nuze-20230331_def.xml	Edgar Link	unprocessable
nuze-20230331_lab.xml	Edgar Link	unprocessable
nuze-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMG
NuZee, Inc. Stock $img

2023 Q2 Form 10-Q Financial Statement

#000149315223017297 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG NuZee, Inc. Stock $img

2023 Q2 Form 10-Q Financial Statement

#000149315223017297 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG
NuZee, Inc. Stock $img